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There is sufficient evidence for pulmonary carcinogenicity of inhaled Cd compounds in rats whereas no such evidence was found in mice and ham-
sters; the evidence in humans has been termed limited, indicating significant species differences in pulmonary response to inhaled Cd. We hypothe-
sized that expression of metallothionein (MT) protein in the lung after inhalation of Cd differs between species thereby providing different degrees of
sequestration of Cd and protection from its effects. Rats and mice were exposed to 100 pg CdCI2 aerosols/mi3 for 4 weeks, and the presence of MT
was determined in lung and free lung cell homogenates as well as by immunocytochemistry in lung sections up to 28 days postexposure. In addi-
tion, pulmonary inflammatory, and cell proliferative responses were determined. Cd exposure significantly increased MT in homogenates of total
lung in both species; however, no significant increase of MT in rat lung tissue after removal of free lung cells by lavage was found whereas MT was
still significantly increased in lavaged mouse lung tissue throughout the postexposure time. In contrast, exposed rats showed significant increases
in MT in the lavageable lung cells and mice did not. Histochemical analysis of lung sections revealed that mainly the epithelial cells of the bronchi,
bronchioli, and alveoli of Cd-exposed mice expressed MT. Mice also exhibited a marked and sustained pulmonary inflammatory and cell proliferative
response upon CdCI2 exposure which was not observed in rats. The retained Cd dose per gram lung was about 2-fold greater in mice, which is con-
sistent with a greater deposition efficiency of inhaled Cd-aerosols in mice. The pulmonary Cd retention halftime was about twice as long in mice
than in rats. The greater MT induction may offer an explanation for the resistance of mice toward the pulmonary carcinogenic effect of inhaled Cd
despite a greater pulmonary inflammatory and cell proliferative effect and a greater retention halftime of lung Cd in this species. - Environ Health
Perspect 102(Suppl 3):257-263 (1994).
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Introduction
CdCI2 aerosol inhalation by rats over an
18-month period resulted in a significant
dose-dependent induction of lung tumors
at concentrations ranging from 12.5 pg/mi3
to 50 pg/m3(1). The highest concentration
resulted in lung tumors in over 70% ofthe
rats. This was a potentially alarming find-
ing in view of the fact that occupational
exposure limits at the time of the report
were generally at 50 pg/m3, and even as
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high as 100 to 200 pg/m3 in the United
States. Subsequent chronic exposure stud-
ies in rats with several different Cd
compounds (i.e., CdSO4, CdO-dust,
CdO-fume, CdS and CdCl2) corroborated
the earlier findings by demonstrating a sim-
ilar pulmonary carcinogenic response from
these inhaled Cd compounds (2). In con-
trast to these unequivocal findings in rats,
Heinrich et al. (3) did not observe a signifi-
cant pulmonary carcinogenic response in
chronic inhalation studies in mice and
hamsters using the same Cd compounds
and exposure concentrations. The evidence
that Cd is a pulmonary carcinogen in
humans has been termed limited by
International Agency for Research on
Cancer (IARC) (4) based on a number of
epidemiologic studies that did not uni-
formly show a significant correlation
between Cd inhalation exposure and lung
cancer; this issue is still controversial (5,6).
The results ofexperimental animal and
epidemiologic studies suggest that the pul-
monary tumorigenic potency ofinhaled Cd
compounds is quite different in different
mammalian species. An important question
relates to the most appropriate animal
model for extrapolation to humans: Do
rats, or mice and hamsters make better
models to study mechanisms ofpulmonary
carcinogenesis relevant for humans?
Another question arising from the animal
data concerns the design of new studies to
investigate mechanisms that may explain
the observed species differences in pul-
monary Cd carcinogenesis. A basic knowl-
edge about the mechanisms involved in
various species for the different responses
(for example in rats vs. mice) would also
contribute greatly to our understanding of
the human disease process.
The studies reported in this paper were
an attempt to compare the pulmonary
responses in rats and mice after subchronic
inhalation exposure to CdCl2 aerosols. Our
hypotheses were that rats and mice respond
differently to the same inhaled Cd concen-
tration with respect to pulmonary inflam-
matory and epithelial cell proliferative
responses (mice < rats) and inducibility of
metallothionein (MT) (mice > rats). These
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Table 1. Pulmonary Cd contentaftera 4-week exposure to CdCI2 aerosol, 100 pg/mr3
Rats Mice
pgCd/lung pgCd/glung pgCd/lung pgCd/glung
Control 0.008±0.02 0.008±0.02 0.028±0.02 0.182 ±0.13
Exposed 7.39 ±0.69 7.22 ±0.41 2.20 ± 0.40 15.00 ± 0.50
n=4.
hypotheses were based on findings from
particle inhalation studies that showed that
mice responded with a lower pulmonary
inflammation and cell proliferation than
rats when chronically exposed to the same
particle concentrationm [e.g., talc particles,
NTP (7)] and that MT will bind and
sequester Cd, thereby diminishing its
potential for cell and DNA damage (8).
The latter mechanism is also supported by
findings in the chronic inhalation studies
with Cd in rats (2) which showed that co-
inhalation exposure ofrats to CdO + ZnO
aerosols could prevent the induction of
lung tumors and by our earlier results
showing that inhalation ofZnO is a much
stronger inducer of MT in the rat lung
than CdO (9).
Methods
Forty-eight male Fischer-344 rats, body-
weight 191 ± 12 g, and 72 male BalbC
mice, body-weight 18.6 ± 0.5 g, were
exposed in whole-body exposure chambers
to nominally 100 pg Cd/in3 as CdCl2
aerosols for 6 hr/day, 5 days/week for 4
weeks. The CdCl2 aerosols were generated
with an ultrasonic nebulizer (Heyer Co,
Bad Ems, Germany). The particle size as
measured by an 8-stage Mercer impactor
(Intox Albuquerque, NM) was 0.38 pim
(mass median aerodynamic diameter) with
a geometric standard deviation of 1.41.
Control rats and mice were sham-exposed
to filtered air. Groups of rats were sacri-
ficed at 1 day, 7 days, and 28 days after ter-
mination of exposure. The Cd dose in the
lung, liver, and kidney was determined at 1
day after exposure following tissue diges-
tion via Cd analysis by atomic emission
spectrometry. At all sacrifice timepoints,
extensive bronchoalveolar lavages (BAL)
were performed by lavaging the excised
lungs ten times with a volume of 5 ml
(rats) or 1 ml (mice) of saline. Cell differ-
ential, protein content, and lactale dehy-
drogenase (LDH) and P-glucuronidase in
the lung lavage were determined as indica-
tors ofan inflammatory response. The pul-
monary circulation was saline-perfused via
the right heart. The right lung lobe was
flash-frozen in liquid nitrogen for measure-
ment of MT protein by the silver-heme
method (10). The left lung lobes were
fixed in 10% formalin and prepared for
histology and for immunohistochemistry of
MT protein using polyclonal antibodies
raised in rabbits (11). After centrifugation
ofthe lavaged cells at 400 gfor 10 min, the
cell pellet and supernatant were also ana-
lyzed for MT protein.
Cellular proliferative responses were
determined by immunohistochemical
methods using 5-bromo-2'-deoxyuridine
(BrDU) subcutaneously administered via
osmotic minipumps and by specific stain-
ing for proliferating cell nuclear antigen
(PCNA). For the BrDU administration,
Alzet osmotic minipumps (Alzet Corp.,
Palo Alto, CA), model 2MLI for rats and
model 2001 for mice, were used. The
delivery rates ofthese pumps are 10 pl /hr
and 1.0 p1/hr. respectively. After subcuta-
neous implantation, the pumps remained
for 4.5 days before the animals were sacri-
ficed for further tissue fixation and prepara-
tion. BrDU concentration in the Alzet
osmotic minipumps was 20 mg/ml. Tissues
were fixed in Bouin's fixative by intratra-
cheal fixative instillation and immersion.
Specific BrDU and PCNA staining was
performed by Veritas Laboratories
(Burlington, NC) by using general
methodologies described by Goldsworthy
(12) and van Dierendonck (13). For

















described by Hall (14), Greenwell (15),
and Foley (16). The use of both markers
for cell proliferation became necessary since
at the earlier sacrifice timepoints (1 and 7
days postexposure) the subcutaneous
BrDU administration had been unsatisfac-
tory. A comparison of the exogenous
marker, BrDU, with the endogenous
marker, PCNA, in our previous studies
(inhaled solid particles) had shown an
excellent agreement with respect to labeling
indices (unpublished). Indeed, in our pre-
sent studies the 28 day sacrifice timepoint
again showed an excellent concordance of
both labeling techniques (Results). BrDU-
or PCNA-stained slides were examined at x
400 using an Olympus AH2 microscope
fitted with a Spectra Services data analysis
system. Three replicate fields, each consist-
ing of 20,000 pm2 by 5 pm thick were
examined. Results are expressed as number
ofcells per 10 mm3.
Results
At the end of the 4-week exposure, the
total Cd in the lungs ofrats was 7.4 ± 0.7
pg and in mice 2.2 ± 0.4 pg (Table 1).
Normalized for lung weight, the respective
lung Cd concentrations were 7.2 ± 0.4
pg/g lung (rats) and 15.0 ± 0.5 pg/g lung
(mice) Thus, mice retained twice as much
ofthe inhaled Cd per gram lung than rats.
There was also a difference with respect to
the cellular distribution of retained Cd
within the lung: In rats, 12% was retained
in the lavageable cells (mainly alveolar
macrophages) and 87% was retained in the
lavaged lung tissue. In contrast, mice
retained only 2% in the lavageable cells and
97% was retained in their lung tissues. In
both species, about 1% of the total lung
a - signifigantly different from control




Figure 1. Relative PMN numbers in BAL of rats and mice at differenttimepoints after a 4-week exposure to CdCI2(100
pg/M3, n=4pergroup). Rats =open bars; mice =hatched bars; control = 100%.
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Table 2 Bronchoalveolar lavage parameters aftera 4-week exposure to CdCI2 aerosol (100pg/m3) orfiltered air(control).
Rats Mirp
Dayafter Total cells Protein nmoles/min/ml Total cells Protein nmoles/min/ml
Exposure (x107) % PMN mg/ml LDH ,-Gluc (xl06) % PMN mg/ml LDH f-Gluc
Control
1 1.53 ±0.15 0.3± 0.1 0.189 ±0.04 37.39 ± 3.64 0.450± 0.038 0.66± 0.33 0.2± 0.1 0.169±0.03 38.69± 16.66 0.217± 0.071
7 1.46 ±0.16 0.9 ± 0.5 0.255 ± 0.10 55.42 ± 36.76 0.408 ± 0.098 0.726 ± 0.12 0.6 ± 0.5 0.163 ± 0.03 27.69 ± 2.65 0.109 ± 0.063
28 1.79± 0.91 0.5±0.2 0.269 ± 0.07 54.17 ± 11.55 0 0.92± 0.16 1.3±0.9 0.179± 0.106 27.50± 6.41 0.064± 0.030
CdCI2
1 1.46 ±0.19 2.0 ± 0.3* 0.170 ± 0.03 42.62 ± 8.33 0.350 ± 0.039 0.71 ± 0.21 35.7 ± 1.0* 0.230 ± 0.07 94.11 ± 35.24* 0.535 ± 0.141*
7 1.46 ±0.14 0.8 ±0.5 0.193 ±0.05 44.84±6.25 0.381 ±0.064 1.00±0.25 20.7± 16.3* 0.168± 0.01 42.66± 9.07* 0.198± 0.093
28 1.21 ±0.21 0.6 ±0.4 0.281 ±0.06 67.72± 35.32 0.257± 0.062 0.86± 0.11 19.1 ±3.5* 0.164± 0.02 43.77± 3.21* 0.161 ±0.064*






Figure 2 BrDU label in lungs ofCdCI2-exposed and control rats and mice 28 days after a 4-week exposure (100 pg/mi3).
Upper left: control rat; lower left: exposed rat; upperright: control mouse; lowerright: exposed mouse. Bar=50 pm.
Cd was recovered in the lung lavage super-
natant.
Main BAL parameters obtained after
the 4-week exposure are shown in Table 2.
The most important finding was that of a
marked difference between exposed rats
and mice with respect to polymorphonu-
clear cells (PMN) appearing in the BAL:
mice exhibited a significant influx ofPMN
in the alveolar space which was sustained
throughout the postexposure observation
period. In contrast, rats showed only a
modest increase in lavageable PMN one
day after the 4-week exposure, which was
significantly less than that observed in mice
and was no longer present by day 7 (Figure
1). BAL protein levels were also increased
in the mouse lungs at 1 day post-exposure
Table 3. Baseline MTconcentrations in lungs ofcontrol rats and mice
Rat Mouse
Total lung 12.3 ±4.3 pg/g lung 25.3 ±6.0pg/g lung*
Lavaged lung 10.2 ± 5.5 pg/g lung 12.2 ± 5.9 pg/g lung
Lavaged free lung cells 1.2 ±0.3 pg/07 cells 22.7 ± 12.2pg/07 cells*
*Significantlydifferentfrom rat, p<0.05(t-test).
which, however, did not reach a level of
statistical significance (Table 2). The cellu-
lar inflammatory response in the mouse
lungs was mirrored in a significant increase
in the lysosomal and cytoplasmic enzymes
P-glucuronidase and LDH during the post-
exposure period but they did not change in
rats (Table 2). Viability ofthe lavaged cells
as determined by trypan blue exclusion was
not significantly changed in both species,
and ranged from 96 to 97% and from 92
to 95% in control and exposed rats and
mice, respectively.
Cellular proliferative responses also
showed significant differences between the
two species: The number ofPCNA-labeled
cells of the alveolar epithelium was
markedly increased in the CdCI2-exposed
mice at 1 and 7 days postexposure com-
pared to control mice. CdCl2-exposed rats
did not show such dramatic increase in
labeled epithelial cells. The pronounced
cell proliferative response in CdCl2-
exposed mouse lungs was still present at 28
days postexposure as demonstrated in
Figure 2 by the increased BrDU label. The
proliferative response appears to parallel
the persistent alveolar inflammatory
response observed by BAL analysis. In con-
trast, the exposed rats do not show a signif-
icant increase of BrDU-labeled cells
(Figure 2). Quantitation of these observa-
tions is depicted in Figure 3, which shows
significant increase in cell labeling of
macrophages and epithelial cells in exposed
mice but not in rats. Lung sections ofthese
animals stained for PCNA showed the
same qualitative differences between
exposed and control rats and mice except
that not as many cells appeared to show the
label; that is probably due to the adminis-
tration of BrDU over a prolonged period
of4.5 days (Methods).
Pulmonary baseline concentrations of
MT were 12.34 ± 4.3 pig/g lung in control
rats and 25.29 ± 5.99 pg/g lung in control
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Table 4:Total MT in lung aftera 4-weekexposureto CdCI2aerosol, 100 pg/m3.
Rats Mice
Days after Control Exposed Control Exposed
Exposure pg MT/lung pg MT/lung pg MT/lung pg MT/lung
1 11.79±4.11 22.24± 1.66* 3.52±.83 7.25± 2.21*
7 13.32 ±2.42 26.89 ±4.19* 3.31 ±.91 7.88± 1.61*
28 27.14 ± 5.01 36.64 ± 2.76* 7.73 ± 2.33 15.06 ± 2.16*
*Significantly differentfrom control, p<0.05(t-test)
mice (Table 3). On day 1 after the 4-week
exposure, these concentrations increased to
21.71 pg/g lung and 46.49 pg/g lung in
rats and mice, respectively. Total MT levels
in the lungs were significantly increased in
both rats and mice at all time points after
CdCl2 exposure relative to the control ani-
mals (Table 4). However, there were
marked differences between rats and mice
when the MT levels ofthe lavaged cells and
those in the extensively lavaged lungs were
compared separately (Figure 4). In the
lavaged lungs of rats, MT levels changed
only slightly and showed a significant
increase (-1.4-fold) only at day 7 after
exposure. In mice, on the other hand, a 3-
fold increase in lung MT was observed
throughout the postexposure period
(Figure 4).
Quite in contrast to the MT increases
in the lavaged lung tissue, the lavaged cells
from the lungs of mice did not show any
change in MT levels after CdCl2 exposure,
whereas the rats showed a large increase in
MT content per lavaged cell, up to 6.5-
fold, which persisted throughout the post-
exposure period (Figure 4). There was also
a significant difference in baseline levels of
MT in the lavaged cells (-99% alveolar












mice. The control mice had an almost 20-
fold greater MT concentration per lavaged
cell than control rats (Table 3). However,
since control mice had about 20-fold fewer
lavageable cells than rats, the absolute MT
content in the free lung cells of both
species was not significantly different.
Likewise, baseline MT concentration per g
control lung after removal of the free
lavageable cells through extensive lung
lavage was not significantly different
between control rats and mice (Table 3).
The finding ofsignificant differences in
pulmonary MT induction between rats and
mice after CdCl exposure was corrobo-
rated by results from immunohistochemi-
cal MT staining: There was intense
staining for MT in the epithelial lining
cells ofthe conducting airways and alveolar
region in the exposed mouse lungs, while
there was only diffuse staining for MT in
these regions in lungs of the exposed rats
(Figure 5).
Discussion
Our hypothesis that Cd inhalation expo-
sure leads to a greater induction of MT in
the lungs of mice than in rats seems to be
confirmed by the results of the present
study with regard to the lung tissue. After
*
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Figure 3. BrDU labeled macrophages and aleolar epithelial cells in control and CdCI2-exposed rats and mice 28 days
aftera4-weekexposure. *Significantlydifferentfrom control.
I-
removal ofthe lavageable free lung cells by
extensive bronchoalveolar lavage, the
lavaged lungs ofmice showed up to 3-fold
greater MT levels following a 4-week expo-
sure to CdCl2 aerosols compared to con-
trols, whereas the lungs ofexposed rats did
not show this significant increase (Figure
4). However, quite the opposite results
were observed with respect to MT induc-
tion in the lavaged free cells. After the 4-
week CdCl2 aerosol exposure, a marked
increase in MT per lavaged cell was found
in rats but not in the exposed mice (Figure
4). This species-specific differential increase
in pulmonary MT content was not seen
upon analysis ofthe total lung, i.e., lavaged
lung tissue plus lavaged free lung cells. In
this case, both rats and mice showed a sig-
nificant increase in lung MT (Table 4), but
it was more prominent in mice than in
rats.
The lavaged cells consisted almost
exclusively of alveolar macrophages in
exposed and control rats and in control
mice, whereas exposed mice had a signifi-
cant fraction of PMN among the lavaged
cell population. However, since MT
increase in lavaged cells was only observed
in rats, it is obvious that this increase
occurred in the alveolar macrophages;
whether this is due to increased MT induc-
tion in alveolar macrophages or to a possi-
ble uptake of alveolar macrophage
extracellular MT induced by other cells in
the alveolar region was not directly investi-
gated. However, since no significant MT
increase was found in the lavaged lung tis-
sues (Figures 4,5) ofrats and since no MT
was detectable in the BAL supernatant, we
believe that an increased expression ofMT
in alveolar macrophages had occurred. This
is also corroborated by results from Hart
and Garvey (17) who showed a significant
increase of MT levels in rat alveolar
macrophages after Cd inhalation exposure.
Previously they had also reported a signifi-
cant increase in lung MT in rats in a dose-
related response to inhaled Cd acetate in
rats (18), which is in line with the overall
increase ofMT we found in rat lungs with-
out lavage in this study. The much greater
increases in lung MT observed by Hart et
al. (18) in rat lungs could be explained by
much greater Cd lung burdens in their
study. In our present study, Cd levels in rat
lungs were 7.4 pg/lung, whereas in the
study by Hart et al. (18) pulmonary Cd
levels ranged from a low of 10 pg/lung to a
high of43 pg/lung.
The significant increase of lung MT
(lavaged lung) in mice but not in rats after
exposure of both species for the same








Figure 4. MTcontent in extensively lavaged lung and in lavaged free lung cells in CdCI2-exposed rats and mice atdiffer-
enttimepoints after a 4-week exposure compared to respective controls (control = 100%). *Significantly different at p <
0.05, t-test. Rats = open bars; mice =hatched bars.
length of time and to the same concentra-
tion of CdCl2 aerosols may provide a
greater protection against a potential pul-
monary carcinogenic effect ofCd for mice.
Such an effect of inhaled Cd compounds
was only observed in rats (2) but not in
mice or hamsters (3). The tumors observed
in those rat studies originated from epithe-
lial cells in the bronchiolar/alveolar region
ofthe lung, and our present studies show a
significant induction of MT after CdCl2
inhalation in epithelial cells of both the
conducting airways and the alveolar region
ofthe mice (Figure 5). It is, therefore, con-
ceivable that retention ofCd in these cells
via sequestration in MT could prevent any
potential genotoxic interaction of Cd with
these cells; the exact mechanism of such
interaction still needs to be investigated.
Such a protective effect ofMT against the
carcinogenic effects of Cd has also been
suggested for other organs (8,19).
An interesting observation in our stud-
ies is that baseline levels oflung tissue MT
(per gram lavaged lung, Table 3) were not
significantly different between control rats
and mice. On the other hand, total base-
line MT concentrations per gram of lung
(including lavageable lung cells) were sig-
nificantly greater in mice due to a higher
baseline level of MT in mouse alveolar
macrophages (Table 3). Such species differ-
ences in MT levels in the unexposed con-
trol organ as well as a differential induction
upon exposure to Cd have to be considered
when evaluating effects on MT expression.
Based on results of a greater inflamma-
tory and cell proliferative response in the
lungs ofmice as compared to rats following
exposure to particles (7) we had hypothe-
sized that we would also see a similar
species difference after CdCl2 inhalation.
In the National Toxicology Program
(NTP) (2) studywith talc and in other par-
ticle studies (20), only rats showed a pul-
monary carcinogenic response whereas
mice did not, consistent with the greater
inflammatory and cell proliferative
response in rats compared to mice.
However, our present results after CdCl2
exposure of both species are not consistent
with our hypothesis; quite in contrast, mice
responded with a much greater and persis-
tent pulmonary inflammation than rats
after the same exposure to CdCl2 aerosols,
and cellular proliferative responses were
also markedly greater in the CdCl2-exposed
mouse lungs compared to the rats. This
unexpected result is in contrast to the idea
that cell proliferative effects might be corre-
lated with an increased risk of tumor inci-
dences (21) since the opposite has been
found after chronic Cd inhalation. Only
rats but not mice responded with a signifi-
cant and large increase in lung tumors.
The resistance of mice against Cd-
induced lung tumors in spite ofthe signifi-
cant responses in inflammation and cell
proliferation should be viewed in the con-
text ofincreased MT expression. It appears
that mice are more sensitive than rats to a
pulmonary inflammatory response of
inhaled cadmium. Proinflammatory
cytokines such as TNF-a and IL-1, poten-
tially released by the interaction ofCd with
pulmonary cells (alveolar macrophages;
epithelial cells), have been shown to induce
MT (22-24). In addition, growth factors
released from activated alveolar
macrophages could lead to the observed
epithelial cell proliferative response (25).
Although the increase in cell proliferation
could potentially make those cells more
vulnerable to a genotoxic Cd effect, the
protection given by the increased cellular
MT content through binding of Cd may
prevent genotoxic interaction of Cd with
DNA. This hypothetical scenario could
explain both the species differences in
inflammation, including cell proliferation,
and pulmonary carcinogenesis.
The different inducibility of MT in
pulmonary tissues and cells in rats vs. mice
is possibly also responsible for differences
RAT MOUSE
Fgure 5. Immunohistochemistry of MT(brown label) in bronchial and alveolartissue of rats and mice 28 days after a 4-
week exposure to CdCI2 aerosols. Left side: lung sections of exposed rats; right side: lung sections of exposed mice.
Control lungs showed onlyminimal staining. Bar=50 pm.
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in pulmonary Cd retention. In mice, only
2% ofthe total pulmonary Cd was retained
in the lavaged cells in contrast to 12% in
rats, which is in line with the observed
greater MT inducibility in rat alveolar
macrophages available for Cd binding. In
fact, the amount ofMT (-10 pg) found in
the lavaged free lung cells (1.46 x 107)
from CdCI2-exposed rats in our study
would suffice to bind the 0.9 pig Cd found
in these lavaged cells. Also of interest that
the pulmonary retention halftime of cad-
mium is about 2-fold longer in mice than
in rats, i.e., a retention halftime of about
70 days in rats versus. -140 days in mice
(data not reported). Data from Heinrich et
al. (3) also point to a longer pulmonary
retention ofCd in mice than in rats, which
might be due partially to the greater MT
content in Cd-exposed mouse lungs and
binding ofCd. An important conclusion is
that a longer retention of Cd in the lung
does not necessarily translate into a greater
risk for inducing lung tumors; it appears
that levels and inducibility of pulmonary
MT are crucial factors. Nonhuman pri-
mates retain pulmonary Cd about 10-fold
longer than rats (26), but this should not
be viewed as being at a greater risk for lung
tumors than rats since nothing is known
about MT levels in primate lungs after Cd
exposure.
With respect to pulmonary Cd reten-
tion and MT levels, the measured MT con-
tent in rat and mouse lungs in our study
would not be sufficient to bind all of the
retained cadmium. For example, at the end
of the 4-week exposure, 22.2 and 7.2 pg
MT (Table 4) were found in the rat and
mouse lungs, respectively. Even completely
saturated with Cd, this would only account
for the binding of about 2.2 and 0.72 pg
Cd, i.e., for about 30% of the actually
retained Cd of 7.4 and 2.2 pg in the lung
(Table 1). This implies that in both rats
and mice almost the same fraction of the
retained pulmonary Cd is not bound to
MT but probably is bound to other pro-
teins. However, the fact that pulmonary
tissue MT, in particular epithelial MT
(Figure 5), is markedly increased in the
mice apparently provides sufficient protec-
tion ofthese target cells against a potential
carcinogenic Cd effect. As discussed in the
preceding section, MT in the lavaged cells
ofrats is sufficient to bind all Cd present in
this fraction. This is also true for MT and
Cd in lavaged mouse cells.
Although our studies indicate that the
rat did not respond with a significant up-
regulation ofMT expression in lung tissue
after Cd exposure, the result should be seen
in relation to the Cd dose. On a per gram
lung basis, mice retained about twice as
much Cd as rats (Table 1), which can be
explained by a greater pulmonary deposi-
tion of the inhaled Cd due to the greater
ventilation rate in mice per g body mass.
Moreover, results ofHart et al. (18) clearly
show that increasing doses of pulmonary
Cd in rats will also lead to an increased
induction of MT in their lungs. We
should, therefore, expect to find signifi-
cant increases in lung MT also in rats
when higher Cd doses in the lung are
retained. Our future studies will be
directed toward establishing dose-
response relationships with respect to pul-
monary MT induction, inflammation,
and cell proliferation in rats and mice to
further investigate species differences.
However, our present results show that
Cd aerosols administered at the same con-
centration to these two species clearly
result in different lung MT inducibility
and inflammatory processes. Thus, the
important question about the most
appropriate animal model for extrapola-
tion to humans needs further attention
and could be addressed in studies involv-
ing in vitro Cd exposures of human and
rodent lung cells and lung tissues through
evaluating and comparing MT expression,
proliferative effects, and other specific
endpoints.
In conclusion, our studies showed that
the same inhaled concentration of CdC12
resulted in a greater pulmonary inflam-
matory response, greater cell proliferative
response, and greater MT expression in
bronchial and alveolar epithelial cells in
mice than in rats. Pulmonary retained Cd
per gram lung was about 2-fold greater in
mice than in rats. Despite the greater
inflammatory and cell proliferative
response a lower pulmonary carcinogenic
effect ofinhaled Cd had been observed in
mice in previous studies. We suggest that
this apparent resistance of mice to pul-
monary carcinogenic effects of Cd is due
to an increased protection against a geno-
toxic effect of cadmium by MT induced
in respective target cells.
NOTEADDED IN PROOF:
At the 1993 spring meeting, IARC deter-
mined that Cd is carcinogenic to humans.
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